|
|
|
Insider
Information: |
Bybee Clinton |
Relationship: |
10% Owner |
City: |
Chicago |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
37,071,986 |
|
Indirect Shares
|
66,802,916 |
|
|
Direct
Value |
$504,305,420 |
|
|
Indirect Value
|
$936,818,410 |
|
|
Total
Shares |
103,874,902 |
|
|
Total
Value |
$1,441,123,830 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-16.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Illumina Inc |
ILMN |
Former 10% Holder |
2004-02-03 |
5,704 |
2004-02-03 |
2,915,298 |
Premium* |
|
Alnylam Pharmaceuticals Inc |
ALNY |
10% Owner |
|
0 |
2004-05-27 |
222,500 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
2004-03-19 |
0 |
2004-03-19 |
2,054,271 |
Premium* |
|
Kythera Biopharmaceuticals Inc |
KYTH |
10% Owner |
2012-10-16 |
2,105,740 |
2012-10-16 |
0 |
Premium* |
|
Fate Therapeutics Inc |
FATE |
10% Owner |
2013-10-04 |
2,473,188 |
2013-10-04 |
0 |
Premium* |
|
Agios Pharmaceuticals Inc |
AGIO |
10% Owner |
2015-02-19 |
3,088,590 |
2014-06-23 |
0 |
Premium* |
|
Sage Therapeutics, Inc. |
SAGE |
10% Owner |
2015-06-18 |
2,124,699 |
2014-07-23 |
0 |
Premium* |
|
Juno Therapeutics, Inc. |
JUNO |
10% Owner |
2016-03-15 |
10,552,390 |
|
0 |
Premium* |
|
Bellerophon Therapeutics Inc |
BLPH |
10% Owner |
2015-02-19 |
965,660 |
|
0 |
Premium* |
|
Xtera Communications, Inc. |
XCOM |
Director, 10% Owner |
|
0 |
2015-11-17 |
1,885,090 |
Premium* |
|
Syros Pharmaceuticals, Inc. |
SYRS |
10% Owner |
2016-07-06 |
4,637,137 |
|
0 |
Premium* |
|
Impinj Inc |
PI |
Director |
2020-10-23 |
17,125 |
2019-11-15 |
0 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
10% Owner |
2017-12-12 |
11,068,749 |
2017-12-12 |
0 |
Premium* |
|
Unity Biotechnology Inc |
UBX |
10% Owner |
2018-05-07 |
0 |
2018-05-07 |
1,682,417 |
Premium* |
|
Gossamer Bio Inc |
GOSS |
10% Owner |
2019-02-12 |
0 |
2019-02-12 |
4,027,958 |
Premium* |
|
Karuna Therapeutics, Inc. |
KRTX |
10% Owner |
2019-07-02 |
0 |
2019-07-02 |
1,681,435 |
Premium* |
|
Beam Therapeutics Inc. |
BEAM |
10% Owner |
2021-03-31 |
2,434 |
2021-03-31 |
3,521,519 |
Premium* |
|
Vir Biotechnology, Inc. |
VIR |
10% Owner |
2022-09-06 |
30,570 |
2022-09-06 |
61,160 |
Premium* |
|
Lyell Immunopharma, Inc. |
LYEL |
10% Owner |
2021-06-21 |
0 |
2021-06-21 |
18,206,358 |
Premium* |
|
Neumora Therapeutics, Inc. |
NMRA |
10% Owner |
|
0 |
2023-12-08 |
30,544,910 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
115 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PI |
Impinj Inc |
|
|
2017-11-09 |
4 |
B |
$24.43 |
$97,720 |
D/D |
4,000 |
4,417 |
0.01 |
- |
|
PI |
Impinj Inc |
|
|
2018-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,023 |
6,440 |
0 |
- |
|
PI |
Impinj Inc |
|
|
2019-08-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,754 |
12,347 |
0 |
- |
|
ILMN |
Illumina Inc |
10% Owner |
|
2003-11-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(300,001) |
3,315,298 |
|
- |
|
ILMN |
Illumina Inc |
10% Owner |
|
2003-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
463 |
5,088 |
|
- |
|
CYCC |
Cyclacel Pharmaceuticals ... |
10% Owner |
|
2004-03-19 |
4 |
A |
$0.00 |
$0 |
I/I |
1,866,771 |
1,866,771 |
|
- |
|
CYCC |
Cyclacel Pharmaceuticals ... |
10% Owner |
|
2004-03-19 |
4 |
B |
$8.00 |
$1,500,000 |
I/I |
187,500 |
2,054,271 |
1.5 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
|
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
222,500 |
|
- |
|
KYTH |
Kythera Biopharmaceutical... |
10% Owner |
|
2012-10-16 |
4 |
OE |
$7.55 |
$920,217 |
D/D |
121,883 |
2,152,006 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
10% Owner |
|
2012-10-16 |
4 |
D |
$19.88 |
$919,768 |
D/D |
(46,266) |
2,105,740 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
10% Owner |
|
2012-10-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030,123 |
2,030,123 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
10% Owner |
|
2013-10-04 |
4 |
A |
$6.00 |
$770,682 |
D/D |
128,447 |
1,639,855 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
10% Owner |
|
2013-10-04 |
4 |
B |
$6.00 |
$4,999,998 |
D/D |
833,333 |
2,473,188 |
2.45 |
- |
|
FATE |
Fate Therapeutics Inc |
10% Owner |
|
2013-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,511,408 |
1,511,408 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
10% Owner |
|
2014-06-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(386,074) |
3,474,664 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
10% Owner |
|
2014-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,249,389 |
4,249,389 |
0 |
- |
|
JUNO |
Juno Therapeutics, Inc. |
10% Owner |
|
2014-12-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,097,015 |
|
- |
|
JUNO |
Juno Therapeutics, Inc. |
10% Owner |
|
2014-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
10,455,375 |
11,552,390 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
10% Owner |
|
2015-01-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,062,345) |
3,187,044 |
0 |
- |
|
BLPH |
Bellerophon Therapeutics ... |
10% Owner |
|
2015-02-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
752,994 |
|
- |
|
BLPH |
Bellerophon Therapeutics ... |
10% Owner |
|
2015-02-19 |
4 |
B |
$12.00 |
$2,551,992 |
D/D |
212,666 |
965,660 |
2.45 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
10% Owner |
|
2015-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(386,074) |
3,088,590 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
10% Owner |
|
2015-06-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,062,345) |
2,124,699 |
0 |
- |
|
JUNO |
Juno Therapeutics, Inc. |
10% Owner |
|
2016-03-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,000,000) |
10,552,390 |
0 |
- |
|
SYRS |
Syros Pharmaceuticals, In... |
10% Owner |
|
2016-06-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
213,333 |
|
- |
|
115 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|